COST-EFFECTIVENESS OF CEFTOLOZANE/TAZOBACTAM AS EMPIRIC THERAPY FOR THE TREATMENT OF COMPLICATED URINARY TRACT INFECTIONS IN COLOMBIA

被引：0
|
作者：
Lasalvia, P. [1 ]
Rosselli, D. [2 ]
Castaneda-Cardona, C. [1 ]
Garzon, J. [3 ]
Hernandez, F. [1 ]
Beltran, C. [4 ]
Rojas, M. [4 ]
Lopez, M. C. [5 ]
Sarpong, E. M. [6 ]
机构：
[1] NeuroEconomix, Bogota, Colombia
[2] Pontificia Univ Javeriana, Bogota, Colombia
[3] Hosp San Ignacio, Bogota, Colombia
[4] Merck Sharp & Dohme Ltd, Bogota, Colombia
[5] Merck Sharp & Dhome, Bogota, Colombia
[6] MERCK & CO Inc, Rabway, NJ USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN35
引用
收藏
页码：S152 / S152
页数：1
相关论文
共 50 条
  • [41] Profile of ceftolozane/tazobactam and its potential in the treatment of complicated intra-abdominal infections
    Skalweit, Marion J.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 2919 - 2925
  • [42] Population pharmacokinetics of tazobactam/ceftolozane in Japanese patients with complicated urinary tract infection and complicated intra-abdominal infection
    Kakara, Makoto
    Larson, Kajal
    Feng, Hwa-ping
    Shiomi, Mari
    Yoshitsugu, Hiroyuki
    Rizk, Matthew L.
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2019, 25 (03) : 182 - 191
  • [43] Ceftolozane-Tazobactam Population Pharmacokinetics and Dose Selection for Further Clinical Evaluation in Pediatric Patients with Complicated Urinary Tract or Complicated lntra-abdominal Infections
    Larson, Kajal B.
    Patel, Yogesh T.
    Willavize, Susan
    Bradley, John S.
    Rhee, Elizabeth G.
    Caro, Luzelena
    Rizk, Matthew L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (06)
  • [44] THERAPY OF COMPLICATED URINARY-TRACT INFECTIONS
    NABER, KG
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 1991, 141 (23-24) : 552 - 555
  • [45] Cost-Effectiveness of a Sublingual Bacterial Vaccine for the Prophylaxis of Recurrent Urinary Tract Infections
    Carrion-Lopez, Pedro
    Martinez-Ruiz, Jesus
    Gimenez-Bachs, Jose Miguel
    Fernandez-Anguita, Pedro Jesus
    Diaz de Mera-Sanchez Migallon, Inmaculada
    Legido-Gomez, Oscar
    Rico-Marco, Saul
    Lorenzo-Sanchez, Marta Victoria
    Salinas-Sanchez, Antonio Santiago
    UROLOGIA INTERNATIONALIS, 2022, : 730 - 736
  • [46] Urinary tract infections in girls: the cost-effectiveness of currently recommended investigative routines
    Harry Stark
    Pediatric Nephrology, 1997, 11 : 174 - 177
  • [47] Urinary tract infections in girls: The cost-effectiveness of currently recommended investigative routines
    Stark, H
    PEDIATRIC NEPHROLOGY, 1997, 11 (02) : 174 - 177
  • [48] Comparative effectiveness of antibiotic therapy for the treatment of urinary tract infections
    Butler, Anne M.
    Keller, Matthew R.
    Durkin, Michael J.
    Dharnidharka, Vikas R.
    Olsen, Margaret A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 378 - 378
  • [49] EMPIRIC ANTIMICROBIAL THERAPY OF SERIOUS URINARY-TRACT INFECTIONS
    FILE, TM
    TAN, JS
    UROLOGY, 1986, 27 (01) : 80 - 85
  • [50] Cefiderocol for treatment of complicated urinary tract infections
    Wagenlehner, Florian M. E.
    Naber, Kurt G.
    LANCET INFECTIOUS DISEASES, 2019, 19 (01): : 22 - 23
12345